These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36335936)

  • 1. A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors.
    Yan L; Huang Y; Ge J; Liu Z; Lu P; Huang B; Gao S; Wang J; Tan L; Ye S; Yu F; Lan W; Xu S; Zhou F; Shi L; Guddat LW; Gao Y; Rao Z; Lou Z
    Cell; 2022 Nov; 185(23):4347-4360.e17. PubMed ID: 36335936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus NiRAN Domains.
    Slanina H; Madhugiri R; Wenk K; Reinke T; Schultheiß K; Schultheis J; Karl N; Linne U; Ziebuhr J
    J Virol; 2023 Jun; 97(6):e0046523. PubMed ID: 37199624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of RNA capping by SARS-CoV-2.
    Park GJ; Osinski A; Hernandez G; Eitson JL; Majumdar A; Tonelli M; Henzler-Wildman K; Pawłowski K; Chen Z; Li Y; Schoggins JW; Tagliabracci VS
    Nature; 2022 Sep; 609(7928):793-800. PubMed ID: 35944563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN domain.
    Wang B; Svetlov D; Artsimovitch I
    Nucleic Acids Res; 2021 Sep; 49(15):8822-8835. PubMed ID: 34352100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis.
    Yan L; Ge J; Zheng L; Zhang Y; Gao Y; Wang T; Huang Y; Yang Y; Gao S; Li M; Liu Z; Wang H; Li Y; Chen Y; Guddat LW; Wang Q; Rao Z; Lou Z
    Cell; 2021 Jan; 184(1):184-193.e10. PubMed ID: 33232691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional insights into the enzymatic plasticity of the SARS-CoV-2 NiRAN domain.
    Small GI; Fedorova O; Olinares PDB; Chandanani J; Banerjee A; Choi YJ; Molina H; Chait BT; Darst SA; Campbell EA
    Mol Cell; 2023 Nov; 83(21):3921-3930.e7. PubMed ID: 37890482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of RNA capping by SARS-CoV-2.
    Park GJ; Osinski A; Hernandez G; Eitson JL; Majumdar A; Tonelli M; Henzler-Wildman K; Pawłowski K; Chen Z; Li Y; Schoggins JW; Tagliabracci VS
    Res Sq; 2022 Feb; ():. PubMed ID: 35194601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading.
    Yan L; Yang Y; Li M; Zhang Y; Zheng L; Ge J; Huang YC; Liu Z; Wang T; Gao S; Zhang R; Huang YY; Guddat LW; Gao Y; Rao Z; Lou Z
    Cell; 2021 Jun; 184(13):3474-3485.e11. PubMed ID: 34143953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional insights into the enzymatic plasticity of the SARS-CoV-2 NiRAN Domain.
    Small GI; Fedorova O; Olinares PDB; Chandanani J; Banerjee A; Choi YJ; Molina H; Chait B; Darst SA; Campbell EA
    bioRxiv; 2023 Sep; ():. PubMed ID: 37808858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit.
    Slanina H; Madhugiri R; Bylapudi G; Schultheiß K; Karl N; Gulyaeva A; Gorbalenya AE; Linne U; Ziebuhr J
    Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33472860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase.
    Shannon A; Fattorini V; Sama B; Selisko B; Feracci M; Falcou C; Gauffre P; El Kazzi P; Delpal A; Decroly E; Alvarez K; Eydoux C; Guillemot JC; Moussa A; Good SS; La Colla P; Lin K; Sommadossi JP; Zhu Y; Yan X; Shi H; Ferron F; Canard B
    Nat Commun; 2022 Feb; 13(1):621. PubMed ID: 35110538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A structural analysis of the nsp9 protein from the coronavirus MERS CoV reveals a conserved RNA binding interface.
    Mani G; El-Kamand S; Wang B; Baker DL; Ataide SF; Artsimovitch I; Cubeddu L; Gamsjaeger R
    Proteins; 2024 Mar; 92(3):418-426. PubMed ID: 37929701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-Derived Natural Non-Nucleoside Analog Inhibitors (NNAIs) against
    Naidu SAG; Mustafa G; Clemens RA; Naidu AS
    J Diet Suppl; 2023; 20(2):254-283. PubMed ID: 34850656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase.
    Zhao J; Guo S; Yi D; Li Q; Ma L; Zhang Y; Wang J; Li X; Guo F; Lin R; Liang C; Liu Z; Cen S
    Antiviral Res; 2021 Jun; 190():105078. PubMed ID: 33894278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SARS-CoV-2 RNA polymerase is a viral RNA capping enzyme.
    Walker AP; Fan H; Keown JR; Knight ML; Grimes JM; Fodor E
    Nucleic Acids Res; 2021 Dec; 49(22):13019-13030. PubMed ID: 34850141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19.
    Jockusch S; Tao C; Li X; Anderson TK; Chien M; Kumar S; Russo JJ; Kirchdoerfer RN; Ju J
    Antiviral Res; 2020 Aug; 180():104857. PubMed ID: 32562705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric Activation of SARS-CoV-2 RNA-Dependent RNA Polymerase by Remdesivir Triphosphate and Other Phosphorylated Nucleotides.
    Wang B; Svetlov V; Wolf YI; Koonin EV; Nudler E; Artsimovitch I
    mBio; 2021 Jun; 12(3):e0142321. PubMed ID: 34154407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein.
    Littler DR; Liu M; McAuley JL; Lowery SA; Illing PT; Gully BS; Purcell AW; Chandrashekaran IR; Perlman S; Purcell DFJ; Quinn RJ; Rossjohn J
    J Biol Chem; 2021 Dec; 297(6):101362. PubMed ID: 34756886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for substrate selection by the SARS-CoV-2 replicase.
    Malone BF; Perry JK; Olinares PDB; Lee HW; Chen J; Appleby TC; Feng JY; Bilello JP; Ng H; Sotiris J; Ebrahim M; Chua EYD; Mendez JH; Eng ET; Landick R; Götte M; Chait BT; Campbell EA; Darst SA
    Nature; 2023 Feb; 614(7949):781-787. PubMed ID: 36725929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir.
    Yin W; Mao C; Luan X; Shen DD; Shen Q; Su H; Wang X; Zhou F; Zhao W; Gao M; Chang S; Xie YC; Tian G; Jiang HW; Tao SC; Shen J; Jiang Y; Jiang H; Xu Y; Zhang S; Zhang Y; Xu HE
    Science; 2020 Jun; 368(6498):1499-1504. PubMed ID: 32358203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.